Physician profile
James T Cornwell
NPI 1659389658
$1,048.76
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.64 · 2021: $116 · 2022: $916.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $560.42 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $72.46 | 2021-2022 | |
| Sanara Medtech INC. | $49.05 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $40.43 | 2022 | |
| Janssen Pharmaceuticals, INC | $39.15 | 2022 | |
| Kerecis Limited | $37.30 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $32.03 | 2021-2022 | |
| Smith+Nephew, INC. | $29.43 | 2022 | |
| Dexcom, INC. | $27.98 | 2022 | |
| Novo Nordisk INC | $25.98 | 2022 | |
| Eisai INC. | $24.80 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.17 | 2022 | |
| Merck Sharp & Dohme LLC | $23.50 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.20 | 2021 | |
| Pfizer INC. | $16.64 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $16.53 | 2022 | |
| Paratek Pharmaceuticals, INC. | $11.69 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Cornwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.